Rosetta Genomics, Ltd.
10 Plaut Street
Science Park
Rehovot,
76706
Israel - Map
Phone: 972 8 948 4755
Fax: 972 8 948 4766
Web Site: http://www.rosettagenomics.com
| Rosetta Genomics, Ltd., a development stage company, develops microRNA-based diagnostic and therapeutic products. MicroRNAs are naturally expressed or produced, using instructions encoded in DNA and are used in regulating protein production. It develops microRNA-based diagnostic programs for various cancers, including lung and respiratory, gastrointestinal, breast, gyneco-oncology, hematology, uro-oncology, skin, and brain cancers, as well as for the identification of the origin of metastases in CUP; and for women's health, including tests for the early detection of preeclampsia and pre-term labor in pregnant women. The company also intends to develop diagnostic products for chronic diseases and liver diseases. In addition, it develops microRNA-based therapeutic products for the treatment of liver cancer and infectious diseases. The company has collaboration and license agreements with The Rockefeller University; Max Planck Innovation GmbH; Johns Hopkins University; National Institute of Health; and Isis Pharmaceuticals, Inc. Rosetta Genomics was founded in 2000 and is based in Rehovot, Israel. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Isaac Bentwich M.D., 47
Founder, Chief Architect |
N/A
| N/A | Mr. Amir Avniel , 35
Chief Exec. Officer, Pres and Pres of Rosetta Genomics Inc |
N/A
| N/A | Dr. Ranit Aharonov Ph.D., 39
Exec. VP of Computational Biology and Exec. VP of IP |
N/A
| N/A | Prof. Zvi Bentwich M.D.,
Chief Scientist and Deputy Chairman of Advisory Board |
N/A
| N/A | Dr. Dalia Cohen Ph.D., 56
Global Head of R&D and Exec. VP |
N/A
| N/A |
|
|
|
Dollar amounts are as of
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 0.00%
Profile
